Ownership history in UBS Group AG · 7 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in PLUS THERAPEUTICS INC (PSTV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 875,846 | +251,972 | +40.4% | 0.00% | $448K | $0.51 |
| 2025 Q3 | ADDED | 623,874 | +536,236 | +611.9% | 0.00% | $427K | $0.68 |
| 2025 Q2 | ADDED | 87,638 | +54,201 | +162.1% | 0.00% | $30K | $0.35 |
| 2025 Q1 | ADDED | 33,437 | +30,238 | +945.2% | 0.00% | $32K | $0.95 |
| 2024 Q2 | REDUCED | 3,199 | -5,700 | -64.1% | 0.00% | $5K | $1.47 |
| 2023 Q4 | ADDED | 8,899 | +3,750 | +72.8% | 0.00% | $16K | $1.75 |
| 2023 Q3 | INITIATED | 5,149 | — | — | 0.00% | $7K | — |
As of 2025 Q4 — sorted by position size